Lisata Therapeutics, Inc.
LSTA • NASDAQ
Lisata Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David J. Mazzo, with a market cap of $45.2M.
Market Cap$45.2M
Employees25.0
CEODavid J. Mazzo
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Lisata Therapeutics, Inc. FAQ
Common questions about Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Lisata Therapeutics, Inc. has approximately 25 employees.